The Changing Environment Around Accelerated Approvals and Regulatory Pathways
PharmaTalkRadio7 Loka 2022

The Changing Environment Around Accelerated Approvals and Regulatory Pathways

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

utelias-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-hereilla
rss-duodecim-lehti
docemilia
rss-poliisin-mieli
rss-kasvatuspsykologiaa-kaikille
rss-totuuden-liepeilla
koodikahvit
rss-ja-ihminen-loi-alyn-aalto-yliopiston-tekoalypodcast